Matt Seefeld is Executive Vice President at MedEvolve and Will Mowe is Executive Director of Rebound Orthopedics and Neurosurgery. Today, Rebound is achieving better bottom-line performance with fewer FTEs. Zero touch claims that require no human intervention now account for 62% of total, and a closed balance net collection rate above benchmark at 98%.
The Future of Generative AI in the Revenue Cycle
Human-generated data is the “secret sauce” to AI’s potential in RCM. The revenue cycle, a cornerstone of healthcare operations, is poised for transformative advancements through generative AI. While traditional AI applications in revenue cycle management (RCM) have leveraged common, system-generated data, the real breakthrough lies in integrating this with human-generated data to unlock unparalleled potential. How does MedEvolve bridge the gap? Explore infographic below.